Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up.
about
The therapy of insulin resistance in other diseases besides type 2 diabetesDrug interventions for the treatment of obesity in children and adolescentsMetformin use in children with obesity and normal glucose tolerance--effects on cardiovascular markers and intrahepatic fat.The effect of glucagon-like peptide-1 receptor agonist therapy on body mass index in adolescents with severe obesity: a randomized, placebo-controlled, clinical trialAn evolving scientific basis for the prevention and treatment of pediatric obesityCarbohydrate modified diet & insulin sensitizers reduce body weight & modulate metabolic syndrome measures in EMPOWIR (enhance the metabolic profile of women with insulin resistance): a randomized trial of normoglycemic women with midlife weight gaiEffects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trialAMPK as Target for Intervention in Childhood and Adolescent ObesityA cross-sectional study of osteocalcin and body fat measures among obese adolescentsEffects of metformin on energy intake and satiety in obese children.Pediatric obesity: etiology and treatment.Assessment of metformin as an additional treatment to therapeutic lifestyle changes in pediatric patients with metabolic syndromeSex hormone-binding globulin, oligomenorrhea, polycystic ovary syndrome, and childhood insulin at age 14 years predict metabolic syndrome and class III obesity at age 24 years.Pharmacotherapy for childhood obesity: present and future prospects.Predictors of weight-loss response with glucagon-like peptide-1 receptor agonist treatment among adolescents with severe obesityExenatide as a weight-loss therapy in extreme pediatric obesity: a randomized, controlled pilot study.Effects of a Comprehensive, Intensive Lifestyle Intervention Combined with Metformin Extended Release in Obese Adolescents.Evaluation of differential effects of metformin treatment in obese children according to pubertal stage and genetic variations: study protocol for a randomized controlled trialA longitudinal study of serum insulin and insulin resistance as predictors of weight and body fat gain in African American and Caucasian children.Assessment and management of obesity in childhood and adolescence.Treatment of obesity-related hypertension in children and adolescents.Topiramate for weight reduction in adolescents with severe obesity.Pediatric obesity pharmacotherapy: current state of the field, review of the literature and clinical trial considerations.Effect of phentermine on weight reduction in a pediatric weight management clinic.The Effect of Eighteen-Month Metformin Treatment in Obese Adolescents: Comparison of Results Obtained in Daily Practice with Results from a Clinical Trial.The "slower" the better.Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial.Treatment of obesity in children and adolescents.[Carbohydrate metabolism disorders among obese children and adolescents. Diabetes mellitus type 2].Omega-3 polyunsaturated fatty acids reduce insulin resistance and triglycerides in obese children and adolescents.Long-term metformin treatment in adolescents with obesity and insulin resistance, results of an open label extension study
P2860
Q26822399-A8AC7936-918A-4014-8B7F-499DBCB4F67AQ28279770-856DAC61-7230-4D19-9221-F13483A655AFQ30413605-28B24E1B-4C97-4D22-B9CC-92E30AA04B44Q33566838-0A515806-7DDD-46DA-B94B-EF63E6D3B89AQ34028763-4EE7B54A-336A-4E39-8786-00707E7F57B7Q34258486-6F14F9F7-A6DD-4A15-866E-9E38AB0B79B2Q34527061-E3D15B08-12D4-44D8-AC21-328BB351C22FQ34557477-C23ACC7E-4B83-4658-9D20-1A30225273B2Q34742767-DB8C802F-A73B-4E35-B928-95E2C8A24706Q35171164-EAD2EE20-21EA-4384-9E60-A43A9A5CAC7BQ35678445-0D945F26-620D-4221-9884-7FDE4B5EFF75Q36099847-34BB1DA4-9AFC-4942-85A1-3AABF5847013Q36160966-133744EE-35A1-4E8F-A2F3-98C50380B9D9Q36468087-4B0F718B-5D55-4928-AC1B-A63682BAED26Q36485989-E225979D-D88F-4497-9512-1A248A928D86Q36934365-01733921-CB78-4FE9-90AC-FC6DFCFB0504Q36979445-161F5974-E10D-433B-A6B2-B2F6DD91DF40Q37106506-D5209989-9539-4D70-846B-8EC94FC4911FQ37553110-DC303A5F-9757-4381-90F4-6802CC26564FQ37942290-E2062394-92EA-4045-8063-B8FF1B875A75Q38087932-AF00AC21-27D5-4F7A-A916-F18CDB84944AQ38229824-0077EF4E-7BAA-4E96-9C93-B22E12B0E321Q38817489-8BC0E4B2-FDAE-402A-B6BE-5A9D5D843B46Q38989047-D6F244BC-26E7-4A46-BD61-B82B99315D12Q39013480-F4EE6225-B5BC-4AD3-99D5-273A286896B9Q39107512-849A408A-E1EF-4556-827C-0A742CEB689FQ41085122-3701B0BE-D9A1-414F-9582-3965E62FEABDQ41777831-FE289A54-0BD8-441F-9DE8-D4E9A871A6A5Q44060809-68CB9F06-C892-48F2-8B7D-05327CA29786Q45157488-1E982D4E-74EB-4C7A-9650-4F6F2CFB2667Q58756822-E391756A-81E5-4B41-9CE4-D303834F9501
P2860
Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Metformin extended release tre ...... trial with 48-week follow-up.
@ast
Metformin extended release tre ...... trial with 48-week follow-up.
@en
type
label
Metformin extended release tre ...... trial with 48-week follow-up.
@ast
Metformin extended release tre ...... trial with 48-week follow-up.
@en
prefLabel
Metformin extended release tre ...... trial with 48-week follow-up.
@ast
Metformin extended release tre ...... trial with 48-week follow-up.
@en
P2093
P2860
P921
P1433
P1476
Metformin extended release tre ...... trial with 48-week follow-up.
@en
P2093
Darrell M Wilson
Glaser Pediatric Research Network Obesity Study Group
Henry A Feldman
Phillip D K Lee
Robert H Lustig
Stavroula V Osganian
Stephanie H Abrams
P2860
P304
P356
10.1001/ARCHPEDIATRICS.2009.264
P407
P577
2010-02-01T00:00:00Z